Search

To help some patients to overcome leukemia, MSK doctors are calling upon patients’ microbiomes — the vast ecosystems of microorganisms that live within us, especially the gut. These microbes appear to help some patients recover from bone marrow and stem cell transplants.

… Friday, April 1, 2022 Bridget Anderson and Charlie Gerstung at the Red Rocks Amphitheatre in Colorado. After recovering from her cord blood transplant, Bridget Anderson, shown here with now-husband Charlie Gerstung, was finally able to travel to Red Rocks in Colorado. Summary To help some patients to

Seven GSK PhD students were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).

… Wednesday, September 13, 2023 This past academic year, seven PhD students enrolled at  the Gerstner Sloan Kettering Graduate School of Biomedical Sciences  (GSK) were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science

Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American Society of Hematology 2024 annual meeting.

… Saturday, December 7, 2024 Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported  results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression to multiple myeloma, a type of rare, incurable blood cancer affecting the

About a third of patients with metastatic breast cancer don’t respond well to the standard anti-estrogen therapies; to find ways to better treat those patients, Memorial Sloan Kettering Cancer Center is studying three new selective estrogen receptor down-regulators (SERDs) in clinical trials.

… Thursday, June 23, 2016 While breast cancer is the most common cancer occurring in women worldwide, it is no longer considered to be a single disease. The presence or absence of an estrogen receptor, a progesterone receptor, and a protein called HER2 distinguish the subtypes of invasive breast cancer

MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.

… Tuesday, December 17, 2024 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2024. Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new therapies, while also making fundamental insights

Memorial Sloan Kettering Cancer Center recently published two retrospective studies with practice-changing insights for improving the treatment and surveillance of patients with oropharyngeal cancer.

… Friday, December 19, 2025 Teams of head and neck radiation oncologists, surgical oncologists and medical oncologists at Memorial Sloan Kettering Cancer Center (MSK) recently published two retrospective studies with practice-changing insights for improving the treatment and surveillance of patients with

Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy.

… Monday, July 11, 2022 Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy, according to a study Memorial Sloan Kettering Cancer Center (MSK) physicians published in JAMA Surgery .  (1) With the increasing availability of genomic

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.

… Thursday, September 23, 2021 No one doctor, institution, or country can cure cancer on their own. The war on cancer must be fought internationally with teams collaborating across political boundaries. That was the key message of the 2021 Forbes China Healthcare Summit, which brought together leaders

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

… Monday, May 13, 2019 Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation, according to the results of our study

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, November 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Piro Lito Receives the Foundation for the National Institutes of Health (FNIH) 4th Annual Trailblazer Prize for Clinician-Scientists Piro Lito Piro Lito, MD, PhD , Medical Oncologist